A recent study has shown that human AML cells (KG-1 (bone marrow) and HL-60 (peripheral blood acute promyelocytic leukemia)) express the NK-1R, and that this receptor mediates the anti-leukemic action of NK-1R antagonists (Table 1) [21]. The gene discussed is TACR1; the disease is acute myeloid leukemia.